Page 133 - 《中国药房》2023年8期
P. 133

ploratory phase Ⅱ trial of oral itraconazole for the treat‐  hibitor for the treatment of hematological malignancies[J].
              ment  of  basal  cell  carcinoma[J].  J  Clin  Oncol,2014,32  Anticancer Drugs,2018,29(10):995-1003.
              (8):745-751.                                   [47]  INFANTE P,ALFONSI R,INGALLINA C,et al. Inhibi‐
          [35]  KELLY R J,ANSARI A M,MIYASHITA T,et al. Targe-    tion of hedgehog-dependent tumors and cancer stem cells
              ting  the  hedgehog  pathway  using  itraconazole  to  prevent   by  a  newly  identified  naturally  occurring  chemotype[J].
              progression of barrett’s esophagus to invasive esophageal   Cell Death Dis,2016,7(9):e2376.
              adenocarcinoma[J]. Ann Surg,2021,273(6):e206-e213.  [48]  ALFONSI  R,BOTTA  B,CACCHI  S,et  al.  Design,
          [36]  MILLER-MOSLIN  K,PEUKERT  S,JAIN  R  K,et  al.        palladium-catalyzed  synthesis,and  biological  investiga‐
              1-amino-4-benzylphthalazines  as  orally  bioavailable  smoo-  tion  of  2-substituted  3-aroylquinolin-4(1H)-ones  as  in‐
              thened  antagonists  with  antitumor  activity[J].  J  Med   hibitors  of  the  hedgehog  signaling  pathway[J].  J  Med
              Chem,2009,52(13):3954-3968.                         Chem,2017,60(4):1469-1477.
          [37]  PEUKERT  S,HE  F,DAI  M,et  al.  Discovery  of  NVP-  [49]  SCHAEFER G I,PEREZ J R,DUVALL J R,et al. Disco-
              LEQ506,a second-generation inhibitor of smoothened[J].   very of small-molecule modulators of the Sonic hedgehog
              ChemMedChem,2013,8(8):1261-1265.                    pathway[J]. J Am Chem Soc,2013,135(26):9675-9680.
          [38]  JIN G H,SIVARAMAN A,LEE K. Development of tala‐  [50]  SOLINAS  A,FAURE  H,ROUDAUT  H,et  al.  Acyl-
              degib as a sonic hedgehog signaling pathway inhibitor[J].   thiourea,acylurea,and  acylguanidine  derivatives  with
              Arch Pharm Res,2017,40(12):1390-1393.               potent hedgehog inhibiting activity[J]. J Med Chem,2012,
          [39]  OAK A S W,BOCHEVA G,KIM T K,et al. Noncalcemic    55(4):1559-1571.
              vitamin  D  hydroxyderivatives  inhibit  human  oral  squa‐  [51]  AGYEMAN A,JHA B K,MAZUMDAR T,et al. Mode
              mous  cell  carcinoma  and  down-regulate  hedgehog  and   and specificity of binding of the small molecule GANT61
              WNT/β -catenin  pathways[J].  Anticancer  Res,2020,40  to GLI determines inhibition of GLI-DNA binding[J]. On‐
              (5):2467-2474.                                      cotarget,2014,5(12):4492-4503.
          [40]  TANG J Y,XIAO T Z,ODA Y,et al. Vitamin D3  inhibits   [52]  GOLDMAN  J,ECKHARDT  S  G,BORAD  M  J,et  al.
              hedgehog signaling and proliferation in murine Basal cell   Phase  I  dose-escalation  trial  of  the  oral  investigational
              carcinomas[J].  Cancer  Prev  Res (Phila),2011,4(5):  hedgehog  signaling  pathway  inhibitor  TAK-441  in  pa‐
              744-751.                                            tients  with  advanced  solid  tumors[J].  Clin  Cancer  Res,
          [41]  DEBERARDINIS A M,RACCUIA D S,THOMPSON E           2015,21(5):1002-1009.
              N,et  al.  Vitamin  D3  analogues  that  contain  modified A-   [53]  BOSCO-CLÉMENT G,ZHANG F,CHEN Z,et al. Tar‐
              and seco-B-rings as hedgehog pathway inhibitors[J]. Eur J   geting Gli transcription activation by small molecule sup‐
              Med Chem,2015,93:156-171.                           presses tumor growth[J]. Oncogene,2014,33(16):2087-
          [42]  BANERJEE U,DEBERARDINIS A M,HADDEN M K.           2097.
              Design,synthesis,and  evaluation  of  hybrid  vitamin   [54]  BEAUCHAMP E M,RINGER L,BULUT G,et al. Arse‐
              D3   side  chain  analogues  as  hedgehog  pathway  inhibitors  nic trioxide inhibits human cancer cell growth and tumor
              [J]. Bioorg Med Chem,2015,23(3):548-555.            development  in  mice  by  blocking  hedgehog/Gli  pathway
          [43]  MASCHINOT C A,HADDEN M K. Synthesis and eva-      [J]. J Clin Invest,2011,121(1):148-160.
              luation  of  vitamin D3  analogues  with  C-11  modifications   [55]  LI  B,FEI  D  L,FLAVENY  C A,et  al.  Pyrvinium  atte-
              as inhibitors of hedgehog signaling[J]. Bioorg Med Chem   nuates hedgehog signaling downstream of smoothened[J].
              Lett,2017,27(17):4011-4014.                         Cancer Res,2014,74(17):4811-4821.
          [44]  赵伟利,董肖椿,陆秀宏,等. 吡唑酞嗪化合物及其制备                   [56]  DIDIASOVA M,SINGH R,WILHELM J,et al. Pirfeni‐
              方法和用途:CN105985321B[P]. 2018-10-26.                  done  exerts  antifibrotic  effects  through  inhibition  of  Gli
          [45]  HOCH L,FAURE H,ROUDAUT H,et al. MRT-92 inhi-      transcription  factors[J].  FASEB  J,2017,31(5):1916-
              bits hedgehog signaling by blocking overlapping binding   1928.
              sites  in  the  transmembrane  domain  of  the  smoothened       (收稿日期:2022-09-13  修回日期:2023-02-12)
              receptor[J]. FASEB J,2015,29(5):1817-1829.                                          (编辑:孙 冰)
          [46]  LIN P,HE Y M,CHEN G D,et al. A novel hedgehog in‐













          中国药房  2023年第34卷第8期                                                China Pharmacy  2023 Vol. 34  No. 8    · 1019 ·
   128   129   130   131   132   133   134   135   136   137   138